+
+

Related Products

  • Revaly
    7 Ratings
    Visit Website
  • AthenaHQ
    30 Ratings
    Visit Website
  • wp2print
    23 Ratings
    Visit Website
  • ScriptSure
    30 Ratings
    Visit Website
  • Docket
    58 Ratings
    Visit Website
  • SciSure
    296 Ratings
    Visit Website
  • JDisc Discovery
    27 Ratings
    Visit Website
  • SDS Manager
    4 Ratings
    Visit Website
  • Pipedrive
    9,703 Ratings
    Visit Website
  • Ango Hub
    15 Ratings
    Visit Website

About

Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization (MPO). It enables the design of novel and easy-to-make compounds in line with a multi-objective blueprint with unprecedented speed, performance, and diversity. Makya offers multiple generative algorithms covering different use cases from hit discovery to lead optimization: fine-tuning generator to find optimal solutions within your chemical space in line with your project blueprint; novelty generator to find new ideas with high novelty for re-scaffolding/hit discovery; forward generator to design a focused library of compounds easily accessible from commercial starting materials. The new Makya 3D module enhances the user experience and scientific utility of Makya. With an extensive set of 3D modeling features in both ligand-based and structure-based pipelines, with Makya 3D you can now calculate 3D scores and use these to guide generations natively in Makya.

About

Recursion is a TechBio company focused on transforming drug discovery by combining biology, data, and artificial intelligence. Founded over a decade ago, the company pioneered the use of large-scale cellular imaging to train AI models that decode the biological drivers of disease. Recursion’s mission is to deliver better medicines through novel insights and precision design, reducing the high failure rates of traditional drug development. Its proprietary Recursion OS platform integrates massive biological datasets with machine learning to accelerate discovery from target identification to clinical development. The company has built an advanced pipeline of potential first-in-class and best-in-class therapies targeting aggressive cancers and rare diseases. Automated wet labs and robotics enable millions of experiments per week, feeding continuous learning into its AI models.

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Audience

Laboratories seeking a solution to visualize, superpose, generate, design, and synthesize new compounds

Audience

Recursion is ideal for researchers, pharmaceutical partners, investors, and healthcare stakeholders interested in AI-driven drug discovery and next-generation therapeutic development

Support

Phone Support
24/7 Live Support
Online

Support

Phone Support
24/7 Live Support
Online

API

Offers API

API

Offers API

Screenshots and Videos

Screenshots and Videos

Pricing

No information available.
Free Version
Free Trial

Pricing

No information available.
Free Version
Free Trial

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Training

Documentation
Webinars
Live Online
In Person

Training

Documentation
Webinars
Live Online
In Person

Company Information

Iktos
France
iktos.ai/makya/

Company Information

Recursion
United States
www.recursion.com

Alternatives

SILCS

SILCS

SilcsBio

Alternatives

AIDDISON

AIDDISON

Merck KGaA
Evo 2

Evo 2

Arc Institute

Categories

Categories

Integrations

Amazon Web Services (AWS)
Google Cloud Platform
Microsoft Azure
Python

Integrations

Amazon Web Services (AWS)
Google Cloud Platform
Microsoft Azure
Python
Claim Iktos and update features and information
Claim Iktos and update features and information
Claim Recursion and update features and information
Claim Recursion and update features and information